The STARGLO trial: glofitamab in combination with gemcitabine and oxaliplatin in R/R DLBCL
Published June 20, 2024
Views 621 | Likes 6 | Comments 0
At a glance
Views
621
Likes
6
Comments
0
Performance vs. channel
Outlier score
Engagement rate
More features coming
We're working on new analytics and tools. Stay tuned.
About
Gareth Gregory, MBBS, PhD, FRACP, FRCPA, Monash University, Monash Health, Melbourne, Australia, discusses the Phase III STARGLO trial (NCT04408638), evaluating glofitamab in combination with gemcitabine and oxaliplatin vs rituximab in combination with gemcitabine and oxaliplatin in patients with relapsed/refractory (R…
- Published
- June 20, 2024
- Made for kids
- No
More features coming
We're working on new analytics and tools. Stay tuned.